Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $17.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Thomas JM (2008) Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol 5: 18–23
Rosenberg SA (2008) Why perform sentinel-lymph-node biopsy in patients with melanoma? Nat Clin Pract Oncol 5: 1
Morton DL et al. (2005) Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242: 302–311
Morton DL et al. (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355: 1307–1317
Morton DL and the MSLT-II Trials Group. Interim update of MSLT-I and MSLT-II. Sixth Biennial International Sentinel Node Society Meeting, Sydney, Australia, 18–20 February 2008
Balch CM et al. (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19: 3622–3634
Morton DL et al. (2007) Sentinel-node biopsy in melanoma. N Engl J Med 356: 419–420
Morton DL et al. (2007) Can completion lymph node dissection be avoided for a positive sentinel node in melanoma? Ann Surg Oncol 14: 2437–2439
Balch CM and Cascinelli N (2007) Sentinel-node biopsy in melanoma. N Engl J Med 356: 420–421
Sabel MS et al. (2007) Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery 141: 728–735
Starritt EC et al. (2005) Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol 12: 18–23
Wen D-R. et al. (2008) Tumor burden and outcome. Sixth Biennial International Sentinel Node Society Meeting, Sydney, Australia, 18–20 February 2008
Scheri RP et al. (2007) Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 14: 2861–2866
The Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) mentioned in this report are supported by funding from the National Cancer Institute (CA29605).
The authors declare no competing financial interests.
About this article
World Journal of Clinical Oncology (2016)
World Journal of Surgical Procedures (2015)
Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma
Cochrane Database of Systematic Reviews (2015)
Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival
Annals of Surgical Oncology (2015)
Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review
British Journal of Dermatology (2014)